COc1cc2c(cc1OC)C1(CCCC1)CNC2c1cccc([N+](=O)[O-])c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?